dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:20:33Z
dc.date.available2014-05-27T11:20:33Z
dc.date.created2014-05-27T11:20:33Z
dc.date.issued2002-12-01
dc.identifierJournal of oral science, v. 44, n. 3-4, p. 117-124, 2002.
dc.identifier1343-4934
dc.identifierhttp://hdl.handle.net/11449/67083
dc.identifier10.2334/josnusd.44.117
dc.identifier2-s2.0-0038048845
dc.identifier2-s2.0-0038048845.pdf
dc.identifier0322020541055900
dc.identifier6097967943008273
dc.identifier0000-0003-3930-4274
dc.description.abstractThe purpose of this study was to evaluate the effects of simvastatin on guided bone regeneration in the mandibles of ovariectomized rats, and to observe their blood cholesterol levels. Seventy female rats were divided into two groups: control and treated, both groups containing normal and ovariectomized rats. A month after ovariectomy a bone defect was created in the mandible, and was covered by a polytetrafluoroethylene membrane. The treated groups received simvastatin orally for 15 or 30 days. The rats were sacrificed 15, 30 or 60 days after surgery, at which time a blood sample was extracted for blood cholesterol level analysis and the mandible was extracted for densitometric, histological and morphometric analysis. All specimens underwent analysis of variance. The ovariectomized animals had higher cholesterol levels than the treated normal animals, and no significant difference was found between the different treatment periods and the sacrifice times. The densitometric, histological and morphometric analysis showed that the treated ovariectomized animals developed more new bone than the control ovariectomized rats, but no significant difference was observed between the treatment periods. It can be concluded that the deficiency of estrogen increased the level of blood cholesterol and that the simvastatin aided new bone formation in the ovariectomized animals.
dc.languageeng
dc.relationJournal of oral science
dc.relation0.853
dc.relation0,397
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectcholesterol
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjecthypocholesterolemic agent
dc.subjectpolitef
dc.subjectsimvastatin
dc.subjectanalysis of variance
dc.subjectanimal
dc.subjectartificial membrane
dc.subjectblood
dc.subjectbone density
dc.subjectbone regeneration
dc.subjectdrug effect
dc.subjectfemale
dc.subjectjaw disease
dc.subjectmandible
dc.subjectovariectomy
dc.subjectpathology
dc.subjectradiodensitometry
dc.subjectrat
dc.subjectstatistics
dc.subjecttissue regeneration
dc.subjectWistar rat
dc.subjectAnalysis of Variance
dc.subjectAnimals
dc.subjectAnticholesteremic Agents
dc.subjectBone Density
dc.subjectBone Regeneration
dc.subjectCholesterol
dc.subjectDensitometry, X-Ray
dc.subjectFemale
dc.subjectGuided Tissue Regeneration
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectMandible
dc.subjectMandibular Diseases
dc.subjectMembranes, Artificial
dc.subjectOvariectomy
dc.subjectPolytetrafluoroethylene
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectSimvastatin
dc.subjectStatistics
dc.titleEffects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución